Back

In vivo near-infrared-II photoacoustic molecular imaging using a myeloperoxidase-targeted nanoprobe to identify vulnerable atherosclerotic plaques

29 August 2026 (10:55 - 11:05)
Organised by: Logo
Congress Presentation Part of: Multimodality imaging and cardiovascular risk Imaging of Peripheral Vascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Wei Tong

Chinese PLA General Hospital, Beijing (China)

5 More presentations in this session

Presentation thumbnail
CMR-ECGI reveals occult electrical remodeling related to myocardial fibrosis in aging populations (MyoFit46)
Doctor F. Morselli (London, GB)
Abstract Slides Video
Presentation thumbnail
Diagnosis of transthyretin amyloid cardiomyopathy using automated myocardial segmentation and CT-based radiomic phenotyping
Doctor T. Tsampras (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Flow-based phenotypes of coronary microvascular dysfunction and cardiovascular risk
Mrs L. Seidelin (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
In vivo imaging of fibroblast activation in mitral annular calcification
Mr A. Jordan (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Sex differences beyond stenosis in quantitative plaque phenotype, coronary anatomy, FFR-CT, and cardiovascular outcomes: the BEYOND-PLAQUE study
Doctor C. Gurevitz (Petah Tikva, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Multimodality imaging and cardiovascular risk
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 10:55 CET
You may be interested in
thumbnail
Congress Session
What makes an atherosclerotic plaque vulnerable? novel perspectives
29 August 2025
thumbnail
Congress Presentation
A targeted and safe strategy for post-infarction anti-inflammatory therapy: cardiac-restricted NLRP3 inhibition via a biomimetic nanocarrier
28 August 2026
thumbnail
Congress Presentation
MPO activity determined by molecular MRI is associated with ruptured and destabilised human atherosclerotic plaques
11 May 2023
thumbnail
Congress Presentation
Longitudinal [¹⁸F]FDG PET/MR assessment of arterial inflammation in prostate cancer patients undergoing androgen deprivation therapy
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources